×
About 213 results

ALLMedicine™ Dysfibrinogenemia Center

Research & Reviews  80 results

Thrombin Time
http://emedicine.medscape.com/article/2086278-overview

May 5th, 2022 - Reference Range Thrombin time is a screening coagulation test designed to assess fibrin formation from fibrinogen in plasma. The reference range for the thrombin time is usually less than 20 seconds (ie, 15-19 seconds), but this depends on the tes...

Thrombin Time
https://emedicine.medscape.com/article/2086278-print

May 5th, 2022 - Thrombin time is a screening coagulation test designed to assess fibrin formation from fibrinogen in plasma. The reference range for the thrombin time is usually less than 20 seconds (ie, 15-19 seconds), but this depends on the test kit/instrument...

Dysfibrinogenemia
https://emedicine.medscape.com/article/199723-print

Apr 28th, 2022 - Practice Essentials Dysfibrinogenemia is a rare coagulation disorder resulting from an abnormal or decreaased level of fibrinogen, which is a 340 kDa glycoprotein produced in the liver, necessary to form blood clots and control bleeding. Dysfibrin...

Dysfibrinogenemia Clinical Presentation
https://emedicine.medscape.com/article/199723-clinical

Apr 28th, 2022 - History In congenital dysfibrinogenemia, bleeding is usually mild and may not manifest until after surgical procedures or major traumatic events. Rarely, however, patients can experience combined hemorrhagic and thrombotic tendencies. In female pa...

Dysfibrinogenemia
https://emedicine.medscape.com/article/199723-overview

Apr 28th, 2022 - Practice Essentials Dysfibrinogenemia is a rare coagulation disorder resulting from an abnormal or decreaased level of fibrinogen, which is a 340 kDa glycoprotein produced in the liver, necessary to form blood clots and control bleeding. Dysfibrin...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  2 results

Genomics of Fibrin Clot Structure in Patients With Constitutional Dysfibrinogenemia
https://clinicaltrials.gov/ct2/show/NCT05233384

Feb 10th, 2022 - Hereditary dysfibrinogenemia results from monoallelic mutation in one of the fibrinogen genes (FGA, FGB, FGG). The spectrum of molecular abnormalities is broad, leading to several subtypes of coagulation disorders with specific biological and clin...

Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage
https://clinicaltrials.gov/ct2/show/NCT04149171

Nov 4th, 2019 - Major hemorrhage in the setting of severe trauma patient is associated with significant morbidity and mortality. Hemorrhage is compounded by trauma induced coagulopathy of which hypo/dysfibrinogenemia and hypoperfusion play a significant role. The...

see more →

News  1 results

Fast Five Quiz: Test Your Knowledge of Venous Thromboembolism
https://reference.medscape.com/viewarticle/902400_2

Dec 3rd, 2018 - Nephrotic syndrome is one of several disease states that increase a patient's risk of developing VTE. VTE associated with nephrotic syndrome appears to be due to a hypercoagulable state resulting from urinary loss of anticoagulant proteins, togeth...

see more →